Here are 10 real companies fitting the brief. Note: stage data moves fast — I've flagged where funding status should be re-verified.
Healthcare
- Tennr — AI agents that read faxes/referrals and automate patient intake workflows for specialty clinics. Fits earlier vintage of thesis; raised seed from a16z before scaling — worth studying as a pattern-match even though now past Series A. (Include as comp, not target.)
- Anterior (fka Co:Helm) — AI clinical reasoning agents for prior authorization on the payer side. NEA-backed, small team, founder is a physician; early enterprise pilots with health plans. Verify current round.
- Hona Health (fka Medplace adjacent space) — if unverifiable, substitute: Cofactor AI — AI agents that draft appeals for denied hospital claims. Pre-seed/seed, launched out of stealth 2024, clear wedge into revenue cycle.
- Tandem Health — AI clinical copilot/scribe agents for European healthcare systems (Sweden). Seed stage, strong regulatory (GDPR/MDR) moat angle.
Legal
- Marveri — AI agents for legal due diligence document review for M&A lawyers. MIT-founded, seed stage, early law firm pilots.
- Solve Intelligence — AI agents for patent drafting and prosecution. YC-backed, seed stage, revenue with IP law firms.
- DraftWise — AI drafting/negotiation agent built on firms' own precedent databases. Ex-Palantir founders; raised seed/Series A boundary — verify.
Finance
- Greenlite — AI agents for AML/KYC compliance operations at fintechs and banks. YC-backed, seed stage, strong logo traction (fintech compliance teams).
- Norm Ai — regulatory compliance converted into executable AI agents for financial institutions. Raised early rounds quickly from Coatue; verify stage — may have passed Series A.
- Hadrius — AI compliance agents for SEC-regulated investment advisors (marketing review, trade surveillance). YC-backed, seed, fast-growing RIA customer base.
Two white-space gaps:
- Agentic audit & assurance. Almost no one is building AI agents for the auditor side (financial audit workpapers, SOC 2 evidence testing, clinical trial monitoring/GCP audits). Everyone builds for the regulated entity; the verification layer is underserved and has forced, recurring demand.
- Cross-border regulatory arbitrage agents. Companies operating across jurisdictions (EU AI Act + FDA + MDR; or multi-state insurance/pharmacy licensing) have no agent that tracks divergent rules and drives filings. Multi-state licensing ops alone (telehealth, insurance producers, money transmitters) is painful, fragmented, and mostly manual today.
Caveat: I have not invented any names, but seed/Series A status shifts quickly — items 1, 7, and 9 in particular may have graduated past your stage filter and should be confirmed against PitchBook/Crunchbase before outreach. Item 3's first-listed name I'm unsure of, so treat Cofactor AI as the pick.